Mercury Laboratories Limited Share Price

BSE: 538964
|
Pharmaceuticals

₹ 760.00

+₹5.00 (0.66%)
1D
Last updated 14 Oct, 2026, 12:52 IST

Mercury Laboratories Limited Share Price Today

As of 14 Oct 2026, Mercury Laboratories Limited share price is ₹760.00. The stock opened at ₹760.00, compared to its previous close of ₹755.00. During today's trading session, Mercury Laboratories Limited share price moved in the range of ₹731.00 to ₹760.00, with an average price of ₹745.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹620.55 and a high of ₹930.00.

₹731.00
0.66% up today
₹760.00
1D LOW
1D HIGH

Mercury Laboratories Limited Returns Calculator

Volume
24
Average traded price
₹746.72
Last traded time
12:52:55 14 Oct
Last traded quantity
11
Circuit
L
H
₹604.00
₹906.00
52-week
L
H
₹620.55
₹930.00
Mkt Cap Cr
92.40
P/E
21.76
P/B
1.56
ROA
5.27%
ROE
8.32%
ROCE
10.75%
Quick Ratio
3.24
EV/EBITDA
10.17
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Mercury Labs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Mercury Labs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0135.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,11,898.66101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,06,129.9632.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Mankind Pharma99,089.5247.326.07.36%11.74%13.13%0.7426.02
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Mercury Laboratories Limited

ISIN
INE947G01011
Sector Market Cap
₹ 92.40 Cr

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, and innovative products. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.

Mercury Laboratories Limited Financial Highlights

  • Revenue: Mercury Laboratories Limited reported revenue of ₹77.90 crore in FY26 vs ₹76.17 crore in FY25. It showed an increase of 2.27% on a yearly basis.
  • Operating Profit: Mercury Laboratories Limited reported an operating profit of ₹6.64 crore in FY26 vs ₹4.66 crore in FY25. It showed an increase of 42.49% on a year-on-year basis.
  • Net Profit: Mercury Laboratories Limited reported a net profit of ₹4.83 crore in FY26 vs ₹3.14 crore in FY25. It showed an increase of 53.82% on a yearly basis.

Mercury Laboratories Limited Quarterly Result Highlights

  • Mercury Laboratories Limited reported revenue of ₹16.01 crore in Jun 2026, compared with ₹21.11 crore in Mar 2026, representing a decrease of 24.16% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported an operating profit of ₹0.39 crore in Jun 2026, compared with ₹1.74 crore in Mar 2026, representing a decrease of 77.59% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported a profit of ₹0.30 crore in Jun 2026, compared with ₹1.23 crore in Mar 2026, reflecting a decrease of 75.61% on a QoQ basis.
  • The earnings per share (EPS) of Mercury Laboratories Limited stood at ₹40.28 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
73.66%
FII
0.00%
Other DII
0.00%
Retail and other
26.34%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
--
1 week
-1.31%
1 month
-3.21%
1 year
-14.06%
3 years
-5.74%
5 years
+5.99%
Day
Open / Close
Change %
13 Oct 26
₹765.00 / ₹755.00
-1.95%
08 Oct 26
₹770.00 / ₹770.00
+0.65%
07 Oct 26
₹790.00 / ₹765.00
-1.92%
05 Oct 26
₹784.00 / ₹780.00
+4.28%
Show more

Mercury Laboratories Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹75.94₹75.10₹75.56₹75.33
Other Income₹1.96₹1.07₹1.09₹1.72
Total Revenue₹77.89₹76.17₹76.65₹77.05
Total Expenses₹70.86₹71.51₹69.73₹69.61
Profit Before Tax₹6.64₹4.66₹6.92₹7.44
Tax₹1.80₹1.52₹1.27₹1.87
Profit After Tax₹4.83₹3.14₹5.65₹5.58
EPS - Basic₹40.28₹26.21₹47.12₹46.49
EPS - Diluted₹40.28₹26.21₹47.12₹46.49

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.64₹4.66₹6.92₹7.44
Income before WC changes₹10.60₹8.14₹10.12₹10.29
Change in Assets-₹2.01-₹4.91₹0.40-₹6.11
Change in Liabilities-₹3.09₹4.03-₹1.04-₹0.63
Change in WC-₹5.11-₹0.89-₹0.64-₹6.73
Cash flow from Operations₹4.24₹4.86₹8.23₹2.45
Cash flow from Investing-₹3.17-₹9.04-₹6.27-₹1.06
Cash flow from Financing₹2.91-₹1.85-₹1.04-₹1.01
Total Cash Flow₹3.99-₹6.03₹0.91₹0.38
Cash (Start of the year)₹2.19₹8.23₹7.32₹6.93
Cash (End of the year)₹6.18₹2.19₹8.23₹7.32

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹34.14₹35.01₹28.12₹24.71
Current Assets₹44.95₹39.22₹39.84₹39.46
Total Assets₹79.08₹74.24₹67.96₹64.16
Current Liabilities₹11.69₹15.08₹12.63₹14.18
Net Current Asset₹33.26₹24.15₹27.20₹25.28
Non-Current Liabilities₹9.32₹5.59₹4.49₹4.36
Equity Capital₹58.08₹53.57₹50.84₹45.63
Total Equity & Liabilities₹79.08₹74.24₹67.96₹64.16
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
760
12
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 12
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
43.51
Neutral
ATR (14)
27.28
Neutral
STOCH(9,6)
8.24
Bullish
STOCH RSI (14)
14.46
Bullish
ADX(9)
29.39
Bearish
UO(9)
33.9
Neutral
ROC(12)
-7.54
Bearish
WillR(14)
-94.85
Bullish
Period
Simple value
Exponential vaue
5D
763.6
764.69
10D
776.01
771.29
20D
781.97
776.56
50D
784.45
782.42
100D
787.3
787.73
Volume trend — traded volume by day
14 Oct0L
13 Oct0L
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Mercury Laboratories Limited
Pharmaceuticals
Add Stock
Add Another

Mercury Laboratories Limited Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.